BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 17439936)

  • 21. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hairy cell leukemia revealed by an isolated neutropenia].
    Diop S; Ndiaye MF; Farah F; Siby T; Thiam D; Diakhate L
    Dakar Med; 2003; 48(3):230-2. PubMed ID: 15776637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complete remission after Rituximab treatment in refractory hairy cell leukemia].
    Petruskevicius I; Bukh A; Mertz H; Johnsen HE
    Ugeskr Laeger; 2008 Jun; 170(26-32):2350. PubMed ID: 18570771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hairy cell leukemia: current concepts.
    Cannon T; Mobarek D; Wegge J; Tabbara IA
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [50-year-old man with weight loss and splenomegaly].
    Austein T; Schmitt A
    Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
    [No Abstract]   [Full Text] [Related]  

  • 26. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
    Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
    Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
    Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N; Saven A
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary antiphospholipid antibody syndrome with left atrial intracardiac thombosis].
    Amato S; Gaeta G; Brancaccio V; Belfiore G
    G Ital Cardiol; 1997 Apr; 27(4):380-6. PubMed ID: 9244743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hairy cell leukaemia with advanced treatment - a case report.
    Momen A; Sarker CB; Siddiqui NI; Huq MH; Jamal MF; Talukder SI; Rahman KM
    Mymensingh Med J; 2003 Jul; 12(2):134-7. PubMed ID: 12894049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress].
    Makita M; Nakamura K; Kono A
    Rinsho Ketsueki; 2005 Nov; 46(11):1196-201. PubMed ID: 16440803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hairy-cell leukemia.
    Saven A
    N Engl J Med; 2001 Nov; 345(20):1500-1. PubMed ID: 11794207
    [No Abstract]   [Full Text] [Related]  

  • 34. Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?
    Urosevic-Maiwald M; Nobbe S; Kerl K; Benz R
    J Dermatol; 2014 Apr; 41(4):329-33. PubMed ID: 24612373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days].
    Heldal D; Tjønnfjord GE; Evensen SA; Juliusson G
    Tidsskr Nor Laegeforen; 1994 Mar; 114(7):800-3. PubMed ID: 7912011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hairy cell leukaemia with severe bone marrow insufficiency. Complete remission after chemotherapy in two patients (author's transl)].
    Marty M; Calvo F; Castaigne S; Flandrin G
    Nouv Presse Med; 1981 Oct; 10(36):2977-9. PubMed ID: 7290952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA).
    Komarnicki M; Kaźmierczak M; Hansz J
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):31-2. PubMed ID: 7503630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Successful treatment of hairy cell leukemia with pentostatin].
    Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retinopathy as the first symptom of hairy cell leukemia].
    Bertram B; Schulte K; Wolf S; Glöckner WM; Reim M
    Klin Monbl Augenheilkd; 1991 Oct; 199(4):295-7. PubMed ID: 1762358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complete remission in a patient with hairy cell leukemia after treatment with 2-chlorodeoxyadenosine].
    Komarnicki M; Kaźmierczak M
    Acta Haematol Pol; 1993; 24(1):77-81. PubMed ID: 8098177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.